<

SANOFI-AVENTIS (EPA:SAN) Press Release: Dupixent® (dupilumab) late-breaking data at AAD show significant improvements in signs and symptoms of moderate-to-severe atopic hand and foot dermatitis

Transparency directive : regulatory news

18/03/2023 15:00



Other stories

23/03/2023 15:51
23/03/2023 17:23
23/03/2023 15:49
23/03/2023 13:07
23/03/2023 15:41
23/03/2023 15:19
23/03/2023 14:20
23/03/2023 14:30
23/03/2023 15:11
23/03/2023 16:45
23/03/2023 16:34
23/03/2023 15:01
23/03/2023 15:10
23/03/2023 04:11
23/03/2023 16:05
23/03/2023 14:34
23/03/2023 17:02
23/03/2023 17:05
23/03/2023 13:13
23/03/2023 14:00
23/03/2023 13:35
23/03/2023 14:18
23/03/2023 17:20
23/03/2023 12:34
23/03/2023 12:02
23/03/2023 15:39
23/03/2023 18:32
23/03/2023 10:30
23/03/2023 14:03
23/03/2023 13:16
23/03/2023 07:00
22/03/2023 18:28
23/03/2023 17:41
22/03/2023 14:06
23/03/2023 17:55
23/03/2023 14:11
23/03/2023 18:09
23/03/2023 15:59